The KaiBiLiTM H. pylori Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of Helicobacter pylori (H. pylori) antigens in human feces specimens to aid in the diagnosis of H. pylori infection.
H. pylori is a spiral-shaped gram negative bacteria, the most common infectious microorganism found in humans, and infects approximately 50% of the world's populations. H. pylori can be transmitted through the ingestion of food or water that is tainted with fecal matter. H. pylori infection is a risk factor for a variety of gastrointestinal diseases including non-ulcer dyspepsia, duodenal and gastric ulcers and active, chronic gastritis and stomach cancer, and MALT (mucous-associated lymphoid tissue) lymphoma.
H. pylori infection can be diagnosed using invasive or noninvasive methods.
H. pylori infection is currently detected by invasive testing methods based on endoscopy and biopsy (i.e. histology, culture) or non-invasive testing methods such as Urea Breath Test (UBT), serologic antibody test and stool antigen test. 10 Another noninvasive method, serology testing, is not recommended for evaluating treatment effectiveness as it is unable to distinguish between active infection and previous exposure to H. pylori.
The KaiBiLiTM H. pylori Antigen Rapid Test detects H. pylori antigen present in the fecal specimen.
The KaiBiLiTM H. pylori Antigen Rapid Test Device is a rapid chromatographic immunoassay for the qualitative detection of H. pylori antigens in human feces specimens, providing results in 15 minutes. The test utilizes antibodies specific for H. pylori antigens to selectively detect H. pylori antigens in human feces specimens.